Should You Buy Nike Stock Before March 31?

North America sales rose 9% in the most recent quarter (up 6% over six months), but Nike's net income totaled $1.5B over the past two quarters, down 31% year-over-year. The stock is down 24% over the past year and trading near a 10-year low; the company has a recent CEO change and faces consumer "trading down" trends and tariff headwinds. Nike will report fiscal 2026 Q3 earnings on March 31; the print could drive stock volatility, but the article argues substantial turnaround risk remains and cautions against buying ahead of results.

Analysis

Nike’s current malaise is less about a single bad quarter and more about a two-layer structural squeeze: (1) margin compression from higher landed costs and promotional intensity, and (2) volume mix shifting toward lower-ASP channels. That combination lengthens the recovery horizon because margin fixes (cost cuts, freight re-routing) are 6–12 month processes while brand-value recovery requires multiple product cycles and sustained pricing power.

Second-order winners and losers are not obvious from headline commentary. Asian cut-make-trim suppliers that can flex capacity to low-cost, high-frequency orders will pick up share from OEM partners that are slower to rebase cost structures; freight and regional distribution hubs in Southeast Asia will see durable volume reflows and higher spot rates if brands accelerate sourcing diversification. Conversely, mid-tier branded incumbents that can’t match promotional cadence risk inventory write-downs that amplify headline retail weakness.

Key near-term catalysts that will reprice the story are guidance on inventory days and margin cadence, the CIO/management messaging on channel mix (wholesale vs DTC), and any tariff-policy signals that change landed-cost assumptions. For investors, the path is binary around the next couple of reported windows: a clean operational plan + concrete cost-savings roadmap can trigger a sharp relief move, while muddled guidance will likely extend underperformance and trigger further multiple compression over 3–12 months.

Key Decisions for Investors

• Buy downside protection: Purchase NKE 4–8 week puts ~5–8% OTM sized at 1–2% of portfolio notional ahead of the upcoming report. R/R: limited premium loss (100% of premium) vs asymmetric payoff if guidance/inventory miss causes a >10–15% gap down; tail risk is a beat that erodes premium (~25–40% decay).
• Pair trade to express structural share shift: Short NKE equity (or buy-to-open short-dated put ladder) and go long discount/fast‑frequency retail (e.g., DG or SKX) 60/40 exposure for a 3–6 month horizon. R/R: isolates mix share movement — downside if NKE executes a convincing re‑pricing/brand defense, upside if consumers continue to trade down and NKE margins compress further.
• Volatility arbitrage around results: Sell a small amount of calendar call premium on NKE (near-term) financed by buying longer-dated OTM puts (6–9 months) to create a cost-efficient bearish skew. R/R: collects premium if IV collapses after a modest beat; preserves downside crash protection if a substantial miss occurs.
• Sector rotation play: Increase exposure to secular growth tech (NVDA) on 6–12 month view as a hedge against cyclical retail weakness — expect rotation of discretionary capital into AI/earnings-growth compounders. R/R: NVDA offers asymmetric upside if macro risk premium drives multiple dispersion; downside if liquidity shock compresses high-growth multiples across the board.